Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid TumorsJulius Strauss, James L. Gulley, Liang Cao et al.|Clinical Cancer Research|2018Cited by 415
Anti–PD-L1 Treatment Induced Central Diabetes InsipidusChen Zhao, Isaac Brownell, Sri Harsha Tella et al.|The Journal of Clinical Endocrinology & Metabolism|2017Cited by 102